Literature DB >> 2537320

Dissociation of inositol trisphosphate from diacylglycerol production in Rous sarcoma virus-transformed fibroblasts.

T J Martins1, Y Sugimoto, R L Erikson.   

Abstract

The metabolism of phosphatidylinositol (PI) and related intermediates was studied in uninfected and Rous sarcoma virus-(RSV) infected chicken embryo fibroblasts (CEFs). Cells infected with wild-type RSV exhibited twofold increases in steady-state concentrations of inositol trisphosphate (IP3) and inositol bisphosphate (IP2) as compared to uninfected CEFs. In addition, increased concentrations of IP3 and IP2 were observed in CEFs infected with the RSV temperature-sensitive transformation mutant NY72-4 when maintained at the permissive temperature (35 degrees C) for greater than 24 h. Slight increases were observed in the amounts of inositol lipids in RSV-transformed cells. Phosphoinositol metabolic changes were related to transformation and not to viral infection since CEFs infected with NY72-4, maintained at the nonpermissive temperature (41.5 degrees C), revealed amounts of phosphoinositols similar to that of uninfected cells. CEFs infected with a transformation-defective virus exhibited PI metabolic changes intermediate between those of transformed and nontransformed cells. NY72-4 CEF exhibited no increase in phosphoinositol concentrations before 8 h incubation at 35 degrees C, indicating that the transformation-specific changes in inositol metabolism were a delayed event. Furthermore, inositol turnover was not activated during this time. In contrast to the case of inositol metabolism, significant increases in diacylglycerol (DAG) concentrations were observed within 15-30 min after shift of NY72-4 CEFs to 35 degrees C. These findings suggest that (a) the major changes in inositol metabolism are specific for RSV-transformed cells; (b) transformation-specific changes in phosphoinositol content in RSV-infected CEFs are not an early effect of the expression of pp60v-src; and (c) increases in the DAG content of transformed cells occur before changes in inositol metabolism, indicating that DAG may be derived from other lipid sources.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537320      PMCID: PMC2115417          DOI: 10.1083/jcb.108.2.683

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  51 in total

Review 1.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

2.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Authors:  Y Sugimoto; M Whitman; L C Cantley; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

3.  Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis.

Authors:  I G Macara; G V Marinetti; P C Balduzzi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

4.  Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.

Authors:  A H Drummond; M Bushfield; C H Macphee
Journal:  Mol Pharmacol       Date:  1984-03       Impact factor: 4.436

5.  Bombesin and phorbol ester stimulate phosphatidylcholine hydrolysis by phospholipase C: evidence for a role of protein kinase C.

Authors:  J G Muir; A W Murray
Journal:  J Cell Physiol       Date:  1987-03       Impact factor: 6.384

6.  Rapid accumulation of inositol phosphates in isolated rat superior cervical sympathetic ganglia exposed to V1-vasopressin and muscarinic cholinergic stimuli.

Authors:  E A Bone; P Fretten; S Palmer; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

7.  The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane.

Authors:  C P Downes; M C Mussat; R H Michell
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

8.  Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate.

Authors:  H Streb; R F Irvine; M J Berridge; I Schulz
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

9.  Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

10.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides.

Authors:  M J Berridge; R M Dawson; C P Downes; J P Heslop; R F Irvine
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

View more
  10 in total

1.  Activation of 6-phosphofructo-2-kinase by pp60v-src is an indirect effect.

Authors:  M J Marchand; L Maisin; L Hue; G G Rousseau
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene.

Authors:  W J Wasilenko; D M Payne; D L Fitzgerald; M J Weber
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

3.  Evidence that v-src and v-fps gene products use a protein kinase C-mediated pathway to induce expression of a transformation-related gene.

Authors:  R Spangler; C Joseph; S A Qureshi; K L Berg; D A Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  A Swiss 3T3 variant cell line resistant to the effects of tumor promoters cannot be transformed by src.

Authors:  M Nori; L K Shawver; M J Weber
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60c-src.

Authors:  F R Gorga; C E Riney; T L Benjamin
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  Phosphatidylinositol metabolism in cells transformed by polyomavirus middle T antigen.

Authors:  E T Ulug; P T Hawkins; M R Hanley; S A Courtneidge
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine.

Authors:  J G Song; L M Pfeffer; D A Foster
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Induction of neurite outgrowth by v-src mimics critical aspects of nerve growth factor-induced differentiation.

Authors:  S M Thomas; M Hayes; G D'Arcangelo; R C Armstrong; B E Meyer; A Zilberstein; J S Brugge; S Halegoua
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters.

Authors:  J Song; D A Foster
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

10.  Maintenance of the differentiated state in skeletal muscle: activation of v-Src disrupts sarcomeres in quail myotubes.

Authors:  L Castellani; M C Reedy; M C Gauzzi; C Provenzano; S Alemà; G Falcone
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.